Precision depends on the full workflow—not one machine name
External-beam radiotherapy delivers ionizing radiation from outside the body. Techniques such as 3D conformal therapy, IMRT, VMAT and stereotactic treatment shape dose differently, but the best choice depends on tumour site, motion, nearby organs and treatment goal.
Planning includes simulation imaging, immobilization, contouring, dose calculation and quality assurance. Daily image guidance checks position, while adaptive planning may be considered when anatomy changes enough to affect dose.
Prior radiation dose maps, not just a summary letter, may be essential when considering retreatment or overlapping fields.
Who may be considered?
This pathway may be discussed when the confirmed diagnosis, disease extent and treatment history make precision radiotherapy a reasonable question—not simply because the technology is available.
- A localized tumour where radiotherapy is part of curative treatment.
- Treatment before or after surgery to improve local control.
- A limited number of metastatic sites considered for focused treatment.
- A symptomatic lesion where radiation may relieve pain, bleeding or pressure.
- A retreatment question requiring reconstruction of previous dose and organ exposure.
What the specialist team must confirm
The radiation oncologist reviews pathology, stage, target visibility, previous radiation, surgery, systemic therapy, motion and nearby organs. Simulation may require contrast, masks, body moulds, breathing control or implanted markers depending on the site.
Key points for this treatment
From simulation to repeatable daily delivery
Each technical step is linked to a clinical purpose, and the plan is checked before the first treatment and throughout the course.
On-treatment review and delayed effects
The team monitors skin, mucosa, swallowing, bowel, urinary, neurologic or other site-specific effects during treatment. Interruptions and supportive care are managed according to severity and treatment intent.
Imaging too early can be difficult to interpret because inflammation and treatment effect may resemble persistent disease. Follow-up timing and expected changes should be explained before travel home.
Limits, burdens and realistic expectations
Radiation cannot eliminate all risk of recurrence and may damage nearby normal tissue. Precision reduces unnecessary exposure but does not make treatment risk-free. Retreatment can be limited by previous dose, and stereotactic techniques are not appropriate for every size, location or pattern of disease.
New severe weakness, loss of bladder or bowel control, uncontrolled bleeding, airway symptoms or rapidly worsening neurologic signs need urgent local assessment rather than waiting for radiation planning.